Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep;78(3):304-306.
doi: 10.1016/j.eururo.2020.04.016. Epub 2020 May 7.

Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence

Andrew Vickers  1 , Sigrid V Carlsson  2 , Matthew Cooperberg  3
Affiliations
Editorial

Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence

Andrew Vickers et al. Eur Urol. 2020 Sep.

Abstract

Guidelines now recommend multiparametric magnetic resonance imaging before prostate biopsy in the work-up for patients with elevated prostate specific-antigen. However, use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence.

PubMed Disclaimer

Figures

Fig. 1 –
Fig. 1 –
Schematic illustration of a prostate gland (orange) with needle biopsies (A–E) directed to an area with prostate cancer with Gleason pattern 3 (blue) and Gleason pattern 4 (red). Adapted from Varma et al [9].
See this image and copyright information in PMC

Comment in

References

    1. Mottet N, van den Bergh RCN, Briers E, et al. European Association of Urology guidelines on prostate cancer. https://uroweb.org/guideline/prostate-cancer/ - PubMed
    1. Bjurlin MA, Carroll PR, Eggener S, et al. Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer. J Urol. 2020;203:706–12. - PMC - PubMed
    1. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 2017;389:815–22. - PubMed
    1. Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378:1767–77. - PMC - PubMed
    1. Fulgham PF, Rukstalis DB, Rubenstein JN, et al. Standard operating procedure for multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer: a collaborative initiative by the American Urological Association and the Society of Abdominal Radiology Prostate Disease Focus Panel. American Urological Association/Society of Abdominal Radiology; 2019. www.auanet.org/guidelines/mri-ofthe-prostate-sop

Publication types